Clinical Trials Directory

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

"Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - U-Propel Study"

Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer

Project Baseline Health Study

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Throat and Other HPV-Related Cancers in Men: Identifying Them Early

Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer

Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)

IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

Measuring Outcomes of Activity in Intensive Care

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Vitamin B12 Supplementation During Pregnancy on Cognitive Development

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck

Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer

Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)

PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection

Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

National Cohort of Colorectal Cancers With Microsatellite Instability

Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation

Identifying Targets of Maladaptive Metabolic Responses in Heart Failure

TracPatch in Total Knee Arthroplasty

Mindfulness Based Eating Awareness Training for Bariatric Surgery Patients

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)

Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC

Leave or Laparoscopic Appendectomy With Normal Findings - a Regional Cohort Study

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Ovarian Tissue Cryopreservation in Children

A Dye for the Detection of Cancer of the Tongue and Mouth

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

"A Trial of Armored CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies"

TIPS Microspheres for Perianal Fistula

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With mTOR Genetic Changes (MATCH - Subprotocol L)

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Non-Anesthetized Plexus Technique for Infant (BPBP) MRI Evaluation

REDUCE LAP-HFREF TRIAL

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma

Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers